Table 3. Determination of COX-2 and PPARγ proteins in ovarian tumours.
| Tissue | Case | Amount of COX-2 protein (ng per mg protein) | Amount of PPARγ protein (μg (cell extract)−1 (well)−1) | 
|---|---|---|---|
| Benign cystadenoma | 1 | ND | ND | 
| 2 | ND | ND | |
| 3 | ND | ND | |
| 4 | ND | ND | |
| Borderline tumour | 1 | ND | 92.9 | 
| 2 | ND | 74.7 | |
| 3 | ND | 57.9 | |
| Carcinoma | 1 | 3.91 | ND | 
| 2 | 3.69 | ND | |
| 3 | 2.65 | ND | |
| 4 | 2.32 | ND | |
| 5 | 2.22 | ND | |
| 6 | 1.98 | ND | |
| 7 | 1.72 | ND | |
| 8 | 1.25 | ND | |
| 9 | ND | ND | |
| 10 | ND | ND | |
| 11 | ND | 70.1 | |
| 12 | ND | 60.2 | 
ND stands for not detectable.